Virtus ETF Advisers’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-137,120
Closed -$302K 547
2024
Q4
$302K Buy
137,120
+23,942
+21% +$55.9K 0.12% 246
2024
Q3
$187K Hold
113,178
0.09% 283
2024
Q2
$251K Buy
+113,178
New +$266K 0.12% 242
2021
Q4
Sell
-17,773
Closed -$214K 386
2021
Q3
$214K Sell
17,773
-1,625
-8% -$23.7K 0.09% 252
2021
Q2
$410K Sell
19,398
-1,759
-8% -$42.4K 0.17% 191
2021
Q1
$593K Buy
21,157
+581
+3% +$17.1K 0.25% 125
2020
Q4
$535K Buy
20,576
+7,134
+53% +$214K 0.22% 137
2020
Q3
$500K Buy
13,442
+1,132
+9% +$44.8K 0.26% 139
2020
Q2
$632K Buy
12,310
+5,075
+70% +$212K 0.3% 104
2020
Q1
$228K Sell
7,235
-1,063
-13% -$56.1K 0.09% 271
2019
Q4
$495K Buy
8,298
+3,154
+61% +$142K 0.08% 204
2019
Q3
$189K Sell
5,144
-286
-5% -$11.3K 0.04% 257
2019
Q2
$253K Sell
5,430
-53
-1% -$2.49K 0.05% 272
2019
Q1
$220K Sell
5,483
-796
-13% -$35.7K 0.47% 84
2018
Q4
$289K Sell
6,279
-5,018
-44% -$242K 0.05% 124
2018
Q3
$501K Sell
11,297
-8,187
-42% -$376K 0.05% 124
2018
Q2
$764K Buy
19,484
+6,541
+51% +$330K 0.68% 56
2018
Q1
$936K Buy
12,943
+6,886
+114% +$506K 0.81% 51
2017
Q4
$399K Sell
6,057
-3,193
-35% -$172K 0.5% 53
2017
Q3
$464K Buy
9,250
+846
+10% +$40.8K 0.06% 96
2017
Q2
$389K Sell
8,404
-14,369
-63% -$528K 0.06% 78
2017
Q1
$804K Buy
22,773
+2,183
+11% +$50K 0.14% 78
2016
Q4
$258K Buy
20,590
+5,050
+32% +$60.1K 0.08% 132
2016
Q3
$215K Hold
15,540
0.1% 135
2016
Q2
$154K Buy
15,540
+4,529
+41% +$75K 0.11% 140
2016
Q1
$186K Buy
+11,011
New +$177K 0.26% 96

Other funds holding ESPR